Healius Limited
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more
Market Cap & Net Worth: Healius Limited (PHCRF)
Healius Limited (PINK:PHCRF) has a market capitalization of $704.35 Million ($704.35 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #9742 globally and #4634 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Healius Limited's stock price $0.97 by its total outstanding shares 726132843 (726.13 Million).
Healius Limited Market Cap History: 2024 to 2025
Healius Limited's market capitalization history from 2024 to 2025. Data shows growth from $704.35 Million to $704.35 Million (0.00% CAGR).
Healius Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Healius Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.52x
Healius Limited's market cap is 0.52 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $704.35 Million | $1.75 Billion | -$645.80 Million | 0.40x | N/A |
| 2025 | $704.35 Million | $1.34 Billion | -$151.20 Million | 0.52x | N/A |
Competitor Companies of PHCRF by Market Capitalization
Companies near Healius Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Healius Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Healius Limited Historical Marketcap From 2024 to 2025
Between 2024 and today, Healius Limited's market cap moved from $704.35 Million to $ 704.35 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $704.35 Million | 0.00% |
| 2024 | $704.35 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Healius Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $704.35 Million USD |
| MoneyControl | $704.35 Million USD |
| MarketWatch | $704.35 Million USD |
| marketcap.company | $704.35 Million USD |
| Reuters | $704.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.